0
Article |

Leukemia Research: Advances in Cell Biology and Treatment

DENIS R. MILLER, MD
Am J Dis Child. 1985;139(2):185. doi:10.1001/archpedi.1985.02140040087034.
Text Size: A A A
Published online

ABSTRACT

Progress in the treatment of childhood acute lymphoblastic leukemia has been remarkable during the past 15 years. Achievement can be quantified by the curability of about 60% of afflicted children; but, as Dr Vincent DeVita stated in his summary comments, "Current studies may be in a rut... perhaps because investigators in this field are victims of their own success." Effective new strategies of future generations of clinical trials must become increasingly dependent on a fuller appreciation and understanding of the biology of this heterogeneous disorder.

In view of the plateau that has been reached in clinical trials, it is not surprising that the main strengths of this book are in the chapters on disease biology. It represents the collected presentations of the Proceedings of the International Symposium on Leukemia Cell Biology and Therapy held in May 1982 in celebration of St Jude Children's Research Hospital's 20th anniversary. Recent advances in

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs